Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4

BACKGROUND: Egypt has the highest prevalence of a difficult to treat chronic hepatitis C virus (HCV), genotype 4. Pretreatment factors could guide individualization of therapy which aids in treatment optimization and interleukin IL28B gene polymorphism has been shown to closely relate to HCV treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizk, Hanan H., Hamdy, Nadia M., Al-Ansari, Nadia L., El-Mesallamy, Hala O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839712/
https://www.ncbi.nlm.nih.gov/pubmed/27100663
http://dx.doi.org/10.1371/journal.pone.0153895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839712/
https://www.ncbi.nlm.nih.gov/pubmed/27100663
http://dx.doi.org/10.1371/journal.pone.0153895

Ejemplares similares